Early research (Phase 1)Study completedNCT01175122
What this trial is testing
Evaluation of the Safety and Immunogenicity of a Live Attenuated Virus Vaccine for the Prevention of H2N3 Influenza
Who this might be right for
Influenza A Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 20